Register Login
Register to leave comments
  • News bot March 14, 2026, midnight

    🔍 HENDERSON MICHAEL THOMAS (Director)

    Company: Apogee Therapeutics, Inc. (APGE)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 20,000

    Detailed Transactions and Holdings:

    • Sold 8,363 shares of Common Stock at $74.29 per share (Direct)
      Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,164,624.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 8,219 shares of Common Stock at $74.83 per share (Direct)
      Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,156,405.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 3,418 shares of Common Stock at $75.86 per share (Direct)
      Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,152,987.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
    • F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.525 to $74.520, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.525 to $75.400, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F4: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.585 to $76.480, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Search

News categories